Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Anastrozole

A non-steroidal aromatase inhibitor, approved in the United States in 1995 for hormone-sensitive breast cancer in postmenopausal women: it blocks the enzyme that turns androgens into oestrogens. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?After menopause, oestrogens no longer come mainly from the ovaries but from tissues such as subcutaneous fat, muscle and liver, where aromatase makes them from androgens: this is the source anastrozole switches off.

AnastrozoleGo to the active ingredient →
AnastrozoleActive ingredientAnastrozoleCat. No. P-A155-001CAS 120511-73-1

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.